0001209191-17-040170.txt : 20170615 0001209191-17-040170.hdr.sgml : 20170615 20170615165206 ACCESSION NUMBER: 0001209191-17-040170 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170613 FILED AS OF DATE: 20170615 DATE AS OF CHANGE: 20170615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gagnon Gilles CENTRAL INDEX KEY: 0001546387 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 17914004 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE. STREET 2: SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-13 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001546387 Gagnon Gilles 11500 S. EASTERN AVE. SUITE 240 HENDERSON NV 89052 1 0 0 0 Common Stock, $0.001 par value 2017-06-13 4 F 0 2500 6.48 D 72500 D Common Stock, $0.001 par value 2017-06-13 4 A 0 10000 0.00 A 82500 D Stock Option (Right to Buy) 6.48 2017-06-13 4 A 0 20000 0.00 A 2027-06-13 Common Stock 20000 20000 D Represents shares withheld by Spectrum to satisfy the Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent. 100% of the restricted shares shall vest on the earlier of (1) June 13, 2018 or (2) the date of the company's 2018 Annual Meeting of Shareholders. 25% of the option shares vested on June 13, 2017. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years. /s/ Kurt A. Gustafson, attorney-in-fact for Gilles Gagnon 2017-06-15